Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Wonderfeel is a longevity-focused bioscience company that develops advanced nutritional supplements designed to optimize cellular health and extend healthspan. The company's primary offering, Young Ergo, is a patented formulation that combines Nicotinamide Mononucleotide (NMN) with the antioxidant Ergothioneine to boost NAD+ levels and protect against oxidative damage. Wonderfeel's research and development efforts are led by Dr. Andrew Salzman, a prominent physician and drug developer with extensive experience in clinical trials and molecular biology. By bridging the gap between pharmaceutical-grade research and consumer wellness, the company aims to provide science-backed solutions for cognitive function, energy metabolism, and systemic aging.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Wonderfeel.